Hutch News

Hutch News

Stories tagged 'national cancer institutes'

Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life

June 7, 2019 | By Fred Hutch News Service staff

A new study led by physicians at Fred Hutchinson Cancer Research Center shows that patients with HIV and one of a variety of potentially deadly cancers can be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.

View story >


Artificial intelligence and cancer

New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations

May 6, 2019 | By Diane Mapes / Fred Hutch News Service

Researchers at Fred Hutch are using a type of artificial intelligence called natural language processing, or NLP, to delve into the pathology reports of metastatic non-small cell lung cancer patients to find if they have two treatable mutations. Dr. Bernardo Goulart tells us why.

View story >


Top cancer groups team up to take on health disparities

Four national organizations push for richer data, more inclusive research to better serve the underserved

July 24, 2017 | By Diane Mapes / Fred Hutch News Service

Four leading cancer organizations joined forces to decry the country's longstanding health disparities and offer recommendations to ensure our most vulnerable populations also benefit from cancer research. Fred Hutch's Dr. Christopher Li, a co-author, talks about the importance of this effort.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.